GC5101F

gc5101f · Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC5101F, covering 2020-07-07 to 2020-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency [Phase 3]